Literature DB >> 10500078

Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice.

M Yin1, M D Wheeler, H Kono, B U Bradford, R M Gallucci, M I Luster, R G Thurman.   

Abstract

BACKGROUND & AIMS: Tumor necrosis factor (TNF)-alpha is associated with increased mortality in alcoholics, but its role in early alcohol-induced liver injury is not fully understood. Recently, it was shown that injury induced by the enteral alcohol delivery model of Tsukamoto and French was reduced by antibodies to TNF-alpha. To obtain clear evidence for or against the hypothesis that TNF-alpha is involved, we studied TNF receptor 1 (TNF-R1, p55) or 2 (TNF-R2, p75) knockout mice.
METHODS: Long-term enteral alcohol delivery was modified for male gene-targeted mice lacking TNF-R1 and TNF-R2. Animals were given a high-fat liquid diet continuously with either ethanol or isocaloric maltose-dextrin as a control for 4 weeks.
RESULTS: Ethanol elevated serum levels of alanine aminotransferase nearly 3-fold in wild-type and TNF-R2 knockout mice but not in TNF-R1 knockout mice. Likewise, ethanol caused severe liver injury in wild-type mice (pathology score, 5.5 +/- 0.6) and TNF-R2 knockout mice (pathology score, 5.0 +/- 0.4), but not in TNF-R1 knockout mice (pathology score, 0.8 +/- 0.4; P < 0.001).
CONCLUSIONS: Long-term ethanol feeding caused liver injury in wild-type and TNF-R2 knockout mice but not in TNF-R1 knockout mice, providing solid evidence in support of the hypothesis that TNF-alpha plays an important role in the development of early alcohol-induced liver injury via the TNF-R1 pathway. Moreover, the long-term enteral ethanol feeding technique we described for the first time for knockout mice provides a useful new tool for alcohol research.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10500078     DOI: 10.1016/s0016-5085(99)70354-9

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  199 in total

1.  Chronic ethanol ingestion induces aortic inflammation/oxidative endothelial injury and hypertension in rats.

Authors:  Kazim Husain; Leon Ferder; Rais A Ansari; Jainarine Lalla
Journal:  Hum Exp Toxicol       Date:  2010-10-04       Impact factor: 2.903

Review 2.  Hepatic stellate cells and innate immunity in alcoholic liver disease.

Authors:  Yang-Gun Suh; Won-Il Jeong
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

3.  Interferon regulatory factor 3 and type I interferons are protective in alcoholic liver injury in mice by way of crosstalk of parenchymal and myeloid cells.

Authors:  Jan Petrasek; Angela Dolganiuc; Timea Csak; Bharath Nath; Istvan Hritz; Karen Kodys; Donna Catalano; Evelyn Kurt-Jones; Pranoti Mandrekar; Gyongyi Szabo
Journal:  Hepatology       Date:  2011-01-10       Impact factor: 17.425

Review 4.  Mechanisms and cell signaling in alcoholic liver disease.

Authors:  Juliane I Beier; Craig J McClain
Journal:  Biol Chem       Date:  2010-11       Impact factor: 3.915

Review 5.  Hepatic non-parenchymal cells: Master regulators of alcoholic liver disease?

Authors:  Wonhyo Seo; Won-Il Jeong
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

6.  Comprehensive characterization of hepatocyte-derived extracellular vesicles identifies direct miRNA-based regulation of hepatic stellate cells and DAMP-based hepatic macrophage IL-1β and IL-17 upregulation in alcoholic hepatitis mice.

Authors:  Akiko Eguchi; Rui Yan; Stephanie Q Pan; Raymond Wu; Jihoon Kim; Yibu Chen; Charles Ansong; Richard D Smith; Mina Tempaku; Lucila Ohno-Machado; Yoshiyuki Takei; Ariel E Feldstein; Hidekazu Tsukamoto
Journal:  J Mol Med (Berl)       Date:  2020-06-18       Impact factor: 4.599

7.  Decreased Macrophage Autophagy Promotes Liver Injury and Inflammation from Alcohol.

Authors:  Ghulam Ilyas; Francesca Cingolani; Enpeng Zhao; Kathryn Tanaka; Mark J Czaja
Journal:  Alcohol Clin Exp Res       Date:  2019-04-29       Impact factor: 3.455

8.  Design and rationale of a multicenter defeat alcoholic steatohepatitis trial: (DASH) randomized clinical trial to treat alcohol-associated hepatitis.

Authors:  Srinivasan Dasarathy; Mack C Mitchell; Bruce Barton; Craig J McClain; Gyongyi Szabo; Laura E Nagy; Svetlana Radaeva; Arthur J McCullough
Journal:  Contemp Clin Trials       Date:  2020-07-31       Impact factor: 2.226

Review 9.  Role of innate immunity in the development of hepatocellular carcinoma.

Authors:  Rajagopal N Aravalli
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

10.  OMP31 of Brucella melitensis 16M impairs the apoptosis of macrophages triggered by TNF-α.

Authors:  Ke Zhang; Hui Wang; Fei Guo; Li Yuan; Wanjiang Zhang; Yuanzhi Wang; Chuangfu Chen
Journal:  Exp Ther Med       Date:  2016-09-02       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.